Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Invio is a private healthcare technology company developing cloud-based software to automate clinical trial data quality monitoring and related clinical operations workflows. Its platform is designed to replace manual and site-visit-heavy monitoring processes with remote, automated review tools that help sponsors and research teams identify data issues, improve enrollment quality, and reduce trial operating costs. The company appears to focus on the clinical development infrastructure layer rather than therapeutics, offering software for biotech, pharmaceutical, and clinical research users. Based in Seattle, Invio was founded in 2016 and has been described as an early-stage, product-ready SaaS company serving the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Invio.